Figure 2.
Kaplan-Meier survival curves for progression-free survival were compared among patients with different lines of therapy (A), EGFR mutation status (B), short-term efficacy (C) and treatment cycle (D). PFS = progression-free survival, EGFR = epidermal growth factor receptor.